全文获取类型
收费全文 | 272916篇 |
免费 | 22170篇 |
国内免费 | 6926篇 |
专业分类
耳鼻咽喉 | 1979篇 |
儿科学 | 5303篇 |
妇产科学 | 3303篇 |
基础医学 | 28022篇 |
口腔科学 | 7957篇 |
临床医学 | 32184篇 |
内科学 | 32353篇 |
皮肤病学 | 3179篇 |
神经病学 | 13052篇 |
特种医学 | 5679篇 |
外国民族医学 | 42篇 |
外科学 | 25241篇 |
综合类 | 45334篇 |
现状与发展 | 22篇 |
一般理论 | 31篇 |
预防医学 | 26982篇 |
眼科学 | 5782篇 |
药学 | 27613篇 |
290篇 | |
中国医学 | 16998篇 |
肿瘤学 | 20666篇 |
出版年
2024年 | 595篇 |
2023年 | 3820篇 |
2022年 | 7228篇 |
2021年 | 10653篇 |
2020年 | 10669篇 |
2019年 | 9076篇 |
2018年 | 8738篇 |
2017年 | 9017篇 |
2016年 | 9497篇 |
2015年 | 9265篇 |
2014年 | 16936篇 |
2013年 | 19666篇 |
2012年 | 15826篇 |
2011年 | 17234篇 |
2010年 | 14721篇 |
2009年 | 13503篇 |
2008年 | 13050篇 |
2007年 | 14062篇 |
2006年 | 12812篇 |
2005年 | 11912篇 |
2004年 | 10310篇 |
2003年 | 8928篇 |
2002年 | 6748篇 |
2001年 | 6232篇 |
2000年 | 5156篇 |
1999年 | 4567篇 |
1998年 | 3416篇 |
1997年 | 3012篇 |
1996年 | 2951篇 |
1995年 | 2749篇 |
1994年 | 2443篇 |
1993年 | 2215篇 |
1992年 | 1862篇 |
1991年 | 1645篇 |
1990年 | 1316篇 |
1989年 | 1265篇 |
1988年 | 1180篇 |
1987年 | 944篇 |
1986年 | 747篇 |
1985年 | 888篇 |
1984年 | 849篇 |
1983年 | 546篇 |
1982年 | 677篇 |
1981年 | 565篇 |
1980年 | 495篇 |
1979年 | 414篇 |
1978年 | 314篇 |
1977年 | 261篇 |
1976年 | 282篇 |
1975年 | 177篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
《Clinical gastroenterology and hepatology》2022,20(3):e380-e397
- Download : Download high-res image (232KB)
- Download : Download full-size image
43.
《Actas urologicas espa?olas》2022,46(9):550-556
ObjectiveProstate cancer (PCa) is the second most common solid tumor in men and the fifth leading cause of cancer-related death. In advanced stage, palliative treatments are used instead of curative therapies. Therefore, finding predictive indicators seems crucial. Patients with castration-resistant prostate cancer (CRPC) that received Dx chemotherapy have been retrospectively reviewed. The aim of this study was to investigate whether docetaxel (Dx)-free interval could have a predictive value for PCa and influence other sequential therapies.Material and methodsThis clinical trial study was performed on 104 patients at Medeniyet University Oncology Clinic in 2018-2020. All CRPC patients had metastases, received Dx as first-line treatment and underwent androgen receptor axis targeted (ARAT) therapy after disease progression. We analyzed patients’ progression time after Dx therapy and the effects on sequential treatment.ResultsAfter Dx therapy, all patients received ARAT (abiraterone (ABI) n: 49 (47.1%) and enzalutamide (ENZ) n: 54 (51.9%)) as a second-line treatment, except for one patient who received cabazitaxel. There was a statistically significant relationship between the Dx-free interval and duration of response to ARAT (P<.001). The response time of ARAT treatment was <10.5 months in all patients whose Dx-free interval period was <9 months.ConclusionsOur findings support the theory that Dx-free interval can be a predictive factor for CRPC. CRPC disease can be classified as Dx-sensitive disease or Dx-resistance disease, based on the Dx-free interval. Decision on subsequent treatments could be made considering this information. 相似文献
44.
45.
目的分析脑出血围手术期护理安全中细节管理的重要性。方法将于2018年6-10月在该院接受治疗的60例脑出血围术期患者作为该研究的常规组。将于2018年11月-2019年3月在该院接受治疗的60例脑出血围术期患者作为该研究的细节组。该院于2018年11月开始实施细节管理,以加强保障脑出血围术期患者的安全。对比两组患者的护理满意度、手术失败率、死亡率、住院时间及日常生活能力。结果细节组护理满意度明显高于常规组(P<0.05)。常规组的手术失败率、死亡率为均高于细节组,差异无统计学意义(P>0.05);细节组的住院时间明显短于常规组(P<0.05),ADL评分明显大于常规组(P<0.05)。结论细节管理在脑出血围手术期护理安全中具有相当重要性,可提升护理满意度,加快恢复速度,提升恢复效果。 相似文献
46.
《Vaccine》2020,38(3):570-577
IntroductionPediatric pneumococcal pneumonia complicated by parapneumonic pleural effusion/empyema (PPE/PE) remains a major concern despite general immunization with pneumococcal conjugate vaccines (PCVs).MethodsIn a nationwide pediatric hospital surveillance study in Germany we identified 584 children <18 years of age with bacteriologically confirmed PPE/PE from October 2010 to June 2018. Streptococcus pneumoniae was identified by culture and/or PCR of blood samples and/or pleural fluid and serotyped.ResultsS. pneumoniae was identified in 256 of 584 (43.8%) children by culture (n = 122) and/or PCR (n = 207). The following pneumococcal serotypes were detected in 114 children: serotype 3 (42.1%), 1 (25.4%), 7F (12.3%), 19A (7.9%), other PCV13 serotypes (4.4%) and non-PCV13 serotypes (7.9%). Between October 2010 and June 2014 serotype 1 (38.1%) and serotype 3 (25.4%) were most prevalent, whereas between July 2014 and June 2018 serotype 3 (62.7%) and non-PCV13 serotypes (15.7%) were dominant. Compared to children with other pneumococcal serotypes, children with serotype 3 associated PPE/PE were younger (median 3.2 years [IQR 2.1–4.3 years] vs. median 5.6 years [IQR 3.8–8.2 years]; p < 0.001) and more frequently admitted to intensive care (43 [89.6%] vs. 48 [73.8%]; p = 0.04). Seventy-six of 114 (66.7%) children with pneumococcal PPE/PE had been vaccinated with pneumococcal vaccines. Thirty-nine of 76 (51.3%) had received a vaccine covering the serotype detected. Thirty of these 39 breakthrough cases were age-appropriately vaccinated with PCV13 and considered vaccine failures, including 26 children with serotype 3, three children with serotype 19A and one child with serotype 1.ConclusionFollowing the introduction of PCV13 in general childhood vaccination we observed a strong emergence of serotype 3 associated PPE/PE in the German pediatric population, including a considerable number of younger children with serotype 3 vaccine breakthrough cases and failures. Future PCVs should not only cover newly emerging serotypes, but also include a more effective component against serotype 3. 相似文献
47.
48.
Caroline E. Sloan Judy Zhong Dinushika Mohottige Rasheeda Hall Clarissa J. Diamantidis Leight E. Boulware Virginia Wang 《Seminars in dialysis》2020,33(6):440-448
Caring for patients with end-stage kidney disease (ESKD) in the United States is challenging, due in part to the complex epidemiology of the disease's progression as well as the ways in which care is delivered. As CKD progresses toward ESKD, the number of comorbidities increases and care involves multiple healthcare providers from multiple subspecialties. This occurs in the context of a fragmented US healthcare delivery system that is traditionally siloed by provider specialty, organization, as well as systems of payment and administration. This article describes the role of care fragmentation in the delivery of optimal ESKD care and identifies research gaps in the evidence across the continuum of care. We then consider the impact of care fragmentation on ESKD care from the patient and health system perspectives and explore opportunities for system-level interventions aimed at improving care for patients with ESKD. 相似文献
49.
50.